Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MSL3 pseudogene 3 (MSL3P3) is a noncoding DNA sequence annotated as a pseudogene homologous to the MSL3 gene. Pseudogenes are genetic sequences that resemble protein-coding genes but lack the ability to code for a functional protein. Unlike the canonical MSL3 gene—which encodes a component of the MSL histone acetyltransferase complex involved in X-chromosome dosage compensation—MSL3P3 is not known to produce a protein or participate in cellular processes. There is no evidence supporting its role as a molecular target for drugs, nor is there evidence of functional or disease-associated activity[4][5]. If research specific to this pseudogene emerges, its functional classification may need to be updated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MSL3 pseudogene 3 (MSL3P3).